相关实验视频
Updated: Jan 16, 2026

06:09
Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
22.9K
这种CaMKII D135N突变阻断了激酶活性,并减少了GluN2B结合
Matthew E Larsen1,2, C Madison Barker1, Raul Satoshi Vargas1
1Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
bioRxiv : the preprint server for biology
|September 26, 2025
概括
这种Ca2+/Calmodulin (CaM) 依存蛋白激酶II (CaMKII) D135N突变影响了酶和结构功能,影响了突触强度和长期强化 (LTP) 诱导.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 长期强化 (LTP) 对突触可塑性和记忆形成至关重要.
- 在LTP中Ca2+/Calmodulin (CaM) 依赖蛋白激酶II (CaMKII) 的作用受到争论,最近的研究表明结构性而不是酶功能.
研究的目的:
- 在LTP的背景下,研究CaMKII D135N突变对其酶和结构功能的影响.
- 重新评估CaMKII在突触强化中的酶与结构活性之间的作用.
主要方法:
- 利用CaMKII D135N突变来评估酶活性 (激酶活性,T286的自酸化) 和结构功能 (与GluN2B结合,共凝结).
- 使用T286A突变体和AS283抑制剂进行比较分析和功能救援实验.
主要成果:
- D135N突变取消了CaMKII酶活性和T286自化.
- D135N突变减少了GluN2B的结合,并阻止了与GluN2B的共凝结,表明对结构功能的影响.
- 通过AS283观察到GluN2B结合的部分救援,类似于T286A突变.
结论:
- D135N突变影响了CaMKII的酶和结构性质,使其在区分这些功能的过程中变得复杂.
- 尽管观察到对结构功能的影响,但当谨慎地解释D135N突变数据时,仍然支持CaMKII在LTP诱导中的结构作用.
更多相关视频
相关概念视频
Calmodulin-dependent Signaling
6.0K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
6.0K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
cAMP-dependent Protein Kinase Pathways
8.3K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.3K
Amplifying Signals via Enzymatic Cascade
17.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
17.5K

